Logo image of TUSK

MAMMOTH ENERGY SERVICES INC (TUSK) Stock Fundamental Analysis

NASDAQ:TUSK - Nasdaq - US56155L1089 - Common Stock - Currency: USD

2.69  -0.13 (-4.61%)

After market: 2.69 0 (0%)

Fundamental Rating

2

Overall TUSK gets a fundamental rating of 2 out of 10. We evaluated TUSK against 59 industry peers in the Energy Equipment & Services industry. While TUSK seems to be doing ok healthwise, there are quite some concerns on its profitability. TUSK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

TUSK had negative earnings in the past year.
In the past year TUSK had a positive cash flow from operations.
TUSK had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: TUSK reported negative operating cash flow in multiple years.
TUSK Yearly Net Income VS EBIT VS OCF VS FCFTUSK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M 400M

1.2 Ratios

The Return On Assets of TUSK (-44.65%) is worse than 98.28% of its industry peers.
Looking at the Return On Equity, with a value of -73.62%, TUSK is doing worse than 93.10% of the companies in the same industry.
Industry RankSector Rank
ROA -44.65%
ROE -73.62%
ROIC N/A
ROA(3y)-4.87%
ROA(5y)-7.19%
ROE(3y)-7.57%
ROE(5y)-10.72%
ROIC(3y)N/A
ROIC(5y)N/A
TUSK Yearly ROA, ROE, ROICTUSK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20 30

1.3 Margins

With a Gross Margin value of 10.31%, TUSK is not doing good in the industry: 89.66% of the companies in the same industry are doing better.
TUSK's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for TUSK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.38%
GM growth 5Y-10.8%
TUSK Yearly Profit, Operating, Gross MarginsTUSK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

More info and screens

5

2. Health

2.1 Basic Checks

TUSK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TUSK has been increased compared to 1 year ago.
TUSK has more shares outstanding than it did 5 years ago.
The debt/assets ratio for TUSK has been reduced compared to a year ago.
TUSK Yearly Shares OutstandingTUSK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
TUSK Yearly Total Debt VS Total AssetsTUSK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

TUSK has an Altman-Z score of -0.57. This is a bad value and indicates that TUSK is not financially healthy and even has some risk of bankruptcy.
TUSK has a Altman-Z score of -0.57. This is amonst the worse of the industry: TUSK underperforms 87.93% of its industry peers.
TUSK has a debt to FCF ratio of 2.14. This is a good value and a sign of high solvency as TUSK would need 2.14 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 2.14, TUSK is doing good in the industry, outperforming 74.14% of the companies in the same industry.
A Debt/Equity ratio of 0.20 indicates that TUSK is not too dependend on debt financing.
TUSK has a better Debt to Equity ratio (0.20) than 70.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 2.14
Altman-Z -0.57
ROIC/WACCN/A
WACC12.03%
TUSK Yearly LT Debt VS Equity VS FCFTUSK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.25 indicates that TUSK has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.25, TUSK is doing good in the industry, outperforming 62.07% of the companies in the same industry.
TUSK has a Quick Ratio of 2.13. This indicates that TUSK is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.13, TUSK is in the better half of the industry, outperforming 75.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 2.13
TUSK Yearly Current Assets VS Current LiabilitesTUSK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for TUSK have decreased strongly by -1230.00% in the last year.
The Revenue for TUSK has decreased by -47.85% in the past year. This is quite bad
The Revenue for TUSK have been decreasing by -28.79% on average. This is quite bad
EPS 1Y (TTM)-1230%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2600%
Revenue 1Y (TTM)-47.85%
Revenue growth 3Y-0.39%
Revenue growth 5Y-28.79%
Sales Q2Q%-38.4%

3.2 Future

The Earnings Per Share is expected to decrease by -36.62% on average over the next years. This is quite bad
TUSK is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -13.19% yearly.
EPS Next Y-21014%
EPS Next 2Y-284.58%
EPS Next 3Y-36.62%
EPS Next 5YN/A
Revenue Next Year-45.75%
Revenue Next 2Y-28.57%
Revenue Next 3Y-13.19%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TUSK Yearly Revenue VS EstimatesTUSK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
TUSK Yearly EPS VS EstimatesTUSK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 4 -4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TUSK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TUSK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TUSK Price Earnings VS Forward Price EarningsTUSK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

TUSK's Price/Free Cash Flow ratio is rather cheap when compared to the industry. TUSK is cheaper than 94.83% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.23
EV/EBITDA N/A
TUSK Per share dataTUSK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

A cheap valuation may be justified as TUSK's earnings are expected to decrease with -36.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-284.58%
EPS Next 3Y-36.62%

More info and screens

0

5. Dividend

5.1 Amount

TUSK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAMMOTH ENERGY SERVICES INC

NASDAQ:TUSK (2/21/2025, 8:00:01 PM)

After market: 2.69 0 (0%)

2.69

-0.13 (-4.61%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)11-01 2024-11-01/bmo
Earnings (Next)02-28 2025-02-28/amc
Inst Owners78.25%
Inst Owner Change-95.86%
Ins Owners2.28%
Ins Owner Change-0.08%
Market Cap129.47M
Analysts85.71
Price Target4.28 (59.11%)
Short Float %0.72%
Short Ratio4.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4622.22%
Min EPS beat(2)-4801.96%
Max EPS beat(2)-4442.48%
EPS beat(4)0
Avg EPS beat(4)-2498.04%
Min EPS beat(4)-4801.96%
Max EPS beat(4)-30.72%
EPS beat(8)1
Avg EPS beat(8)-1276.37%
EPS beat(12)3
Avg EPS beat(12)-621.02%
EPS beat(16)3
Avg EPS beat(16)-538.9%
Revenue beat(2)1
Avg Revenue beat(2)0.36%
Min Revenue beat(2)-16.85%
Max Revenue beat(2)17.56%
Revenue beat(4)1
Avg Revenue beat(4)-10.68%
Min Revenue beat(4)-23.71%
Max Revenue beat(4)17.56%
Revenue beat(8)1
Avg Revenue beat(8)-10.46%
Revenue beat(12)3
Avg Revenue beat(12)-4.73%
Revenue beat(16)5
Avg Revenue beat(16)0.73%
PT rev (1m)0%
PT rev (3m)-14.29%
EPS NQ rev (1m)-1300%
EPS NQ rev (3m)-1300%
EPS NY rev (1m)-17.61%
EPS NY rev (3m)-17.61%
Revenue NQ rev (1m)-9.43%
Revenue NQ rev (3m)-9.43%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.08%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.69
P/FCF 4.23
P/OCF 2.83
P/B 0.48
P/tB 0.5
EV/EBITDA N/A
EPS(TTM)-2.26
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)0.64
FCFY23.65%
OCF(TTM)0.95
OCFY35.29%
SpS3.9
BVpS5.58
TBVpS5.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -44.65%
ROE -73.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.31%
FCFM 16.33%
ROA(3y)-4.87%
ROA(5y)-7.19%
ROE(3y)-7.57%
ROE(5y)-10.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.38%
GM growth 5Y-10.8%
F-Score2
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 2.14
Debt/EBITDA N/A
Cap/Depr 57.03%
Cap/Sales 8.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.25
Quick Ratio 2.13
Altman-Z -0.57
F-Score2
WACC12.03%
ROIC/WACCN/A
Cap/Depr(3y)23.38%
Cap/Depr(5y)21.57%
Cap/Sales(3y)4.1%
Cap/Sales(5y)4.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1230%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2600%
EPS Next Y-21014%
EPS Next 2Y-284.58%
EPS Next 3Y-36.62%
EPS Next 5YN/A
Revenue 1Y (TTM)-47.85%
Revenue growth 3Y-0.39%
Revenue growth 5Y-28.79%
Sales Q2Q%-38.4%
Revenue Next Year-45.75%
Revenue Next 2Y-28.57%
Revenue Next 3Y-13.19%
Revenue Next 5YN/A
EBIT growth 1Y-968.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year65.7%
EBIT Next 3Y43.91%
EBIT Next 5YN/A
FCF growth 1Y256.25%
FCF growth 3Y291.39%
FCF growth 5Y-42.74%
OCF growth 1Y596.6%
OCF growth 3Y64.9%
OCF growth 5Y-39.48%